| Literature DB >> 34092243 |
Shuang Peng1, Jiangang Wang1, Yuanming Xiao1, Lu Yin2, Yaguang Peng3, Lin Yang4,5, Pingting Yang1, Yaqin Wang1, Xia Cao1, Xiaohui Li6,7, Ying Li8,9.
Abstract
BACKGROUND: Arterial stiffness is an independent cardiovascular risk factor. However, the association between sodium/potassium intake and vascular stiffness was inconsistent. Therefore, a large community-based cross-sectional study was performed to try and achieve more definitive conclusion.Entities:
Keywords: Carotid plaque; Estimated urinary potassium excretion (eUKE); Estimated urinary sodium excretion (eUNaE); Intima-media thickness (IMT)
Year: 2021 PMID: 34092243 PMCID: PMC8182948 DOI: 10.1186/s12937-021-00710-8
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 3.271
Fig. 1Flow chart of participant selection. Note: TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FSG, fasting serum glucose; IMT, Intima-media thickness; CCA, common carotid artery; BIF, bifurcation carotid artery; eUNaE, estimated urinary sodium excretion; eUKE, estimated urinary potassium excretion
Characteristics of participants with or without carotid artery plaque
| Characteristics (mean ± SD) | Total ( | Without plaque ( | With plaque ( | |
|---|---|---|---|---|
| Age (years) | 48.66 ± 10.46 | 45.79 ± 9.71 | 55.31 ± 9.00 | < 0.001 |
| BMI (kg/m2) | 24.62 ± 3.19 | 24.56 ± 3.25 | 24.75 ± 3.04 | 0.002 |
| SBP (mmHg) | 125.32 ± 16.32 | 123.04 ± 15.23 | 130.60 ± 17.49 | < 0.001 |
| DBP (mmHg) | 77.04 ± 11.54 | 76.01 ± 11.31 | 79.41 ± 11.72 | < 0.001 |
| FSG (mmol/L) | 5.69 ± 1.46 | 5.56 ± 1.21 | 6.01 ± 1.89 | < 0.001 |
| TC (mmol/L) | 5.11 ± 0.98 | 5.05 ± 0.97 | 5.27 ± 1.00 | < 0.001 |
| TG (mmol/L) | 1.92 ± 1.79 | 1.90 ± 1.85 | 1.98 ± 1.64 | 0.013 |
| LDL-C (mmol/L) | 2.91 ± 0.85 | 2.85 ± 0.83 | 3.04 ± 0.88 | < 0.001 |
| HDL-C (mmol/L) | 1.34 ± 0.31 | 1.35 ± 0.31 | 1.33 ± 0.30 | 0.001 |
| Estimated UNa (g/day) 2 | 4.32 ± 1.15 | 4.32 ± 1.15 | 4.32 ± 1.14 | 0.56 |
| Estimated UK (g/day) 2 | 2.11 ± 0.45 | 2.13 ± 0.46 | 2.08 ± 0.45 | < 0.001 |
| Na/K ratio | 2.10 ± 0.65 | 2.09 ± 0.61 | 2.14 ± 0.73 | < 0.001 |
| Male sex (%) | 37.4 | 40.1 | 31.2 | < 0.001 |
| Current alcohol users (%) | 33.1 | 32.4 | 34.6 | 0.006 |
| Current smokers (%) | 27.6 | 25.7 | 31.9 | < 0.001 |
| Hypertension3 | 32.6 | 26.1 | 47.7 | < 0.001 |
| Dyslipidemia4 | 37.5 | 34.9 | 43.3 | < 0.001 |
| Diabetes mellitus5 (%) | 8.3 | 6.0 | 13.4 | < 0.001 |
| CVD (%) | 1.6 | 1.0 | 3.1 | < 0.001 |
Note: SD standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FSG fasting serum glucose, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, UNa urinary sodium excretion, UK urinary potassium excretion;
1 P were obtained between those with or without plaque using the two-sample nonparametric Wilcoxon test and the chi-square test for categorical variables
2 24-h urinary sodium, potassium, and creatinine levels were estimated using the Kawasaki formula
3 Hypertension was defined as self-reported hypertension diagnosed by a physician, self-reported regular use of antihypertensive medications, or systolic/diastolic blood pressure at recruitment ≥140/90 mmHg
4 Dyslipidemia was defined as meeting any of the following criteria: 1) TC ≥ 6.22 mmol/L; 2) LDL-C ≥ 4.14 mmol/L; 3) HDL-C < 1.04 mmol/L; 4) TG ≥2.26 mmol/L; 5) self-reported dyslipidemia or use of lipid-lowering medications;
5 Diabetes mellitus was defined as self-reported diabetes diagnosed by a physician, self-reported regular use of antidiabetic medications, or fasting glucose at recruitment ≥7.0 mmol/L.
Adjusted associations of carotid plaque and IMT with eUNaE, eUKE and the Na/K ratio
| Variables | eUNaE | eUKE | Na/K ratio | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Model 1 ( | 0.99 | 0.96, 1.03 | 0.68 | 0.81 | 0.74, 0.88 | < 0.01 | 1.14 | 1.08–1.21 | < 0.01 |
| Model 2 ( | 1.03 | 0.99, 1.07 | 0.12 | 1.00 | 0.91, 1.10 | 0.99 | 1.07 | 1.01–1.14 | 0.03 |
| Model 3 ( | 1.03 | 0.99, 1.07 | 0.11 | 1.02 | 0.93, 1.12 | 0.69 | 1.06 | 1.00–1.13 | 0.048 |
| Model 1 ( | 0.004 | 0.002, 0.006 | < 0.01 | 0.004 | −0.001, 0.008 | 0.12 | 0.006 | 0.002, 0.009 | < 0.01 |
| Model 2 ( | 0.002 | 0.000, 0.003 | 0.04 | 0.001 | −0.003, 0.005 | 0.62 | 0.003 | 0.000, 0.006 | 0.09 |
| Model 3 ( | 0.002 | 0.000, 0.004 | 0.04 | 0.001 | −0.003, 0.006 | 0.54 | 0.003 | 0.000, 0.005 | 0.10 |
| Model 1 ( | 0.004 | 0.000, 0.007 | 0.03 | −0.005 | −0.013, 0.003 | 0.23 | 0.013 | 0.007, 0.019 | < 0.01 |
| Model 2 ( | 0.001 | −0.002, 0.004 | 0.61 | −0.009 | −0.016, − 0.001 | 0.02 | 0.008 | 0.003, 0.013 | < 0.01 |
| Model 3 ( | 0.001 | −0.002, 0.004 | 0.60 | −0.008 | −0.015, − 0.001 | 0.03 | 0.008 | 0.003, 0.013 | < 0.01 |
Model 1 was not adjusted for other factors
Model 2 was adjusted for age, sex, body mass index, smoking, and alcohol consumption
Model 3 was adjusted for age, sex, body mass index, smoking, alcohol consumption, hypertension, diabetes mellitus, dyslipidemia and cardiovascular disease
Fig. 2Forest plots of changes in carotid plaque and IMT per unit increase in ratio for estimated urinary sodium to potassium excretion. Note: BMI, body mass index; carotid IMT, carotid artery intima-media thickness; CCA-IMT, common carotid artery intima-media thickness; BIF-IMT, bifurcation carotid artery intima-media thickness; Na/K ratio, ratio of estimated urinary sodium excretion to potassium excretion. Adjusted for age, sex, BMI, smoking, alcohol use, hypertension, diabetes mellitus, dyslipidemia and cardiovascular disease